AB - International Health Care Portfolio I AccRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 15.7 | 25.4 | 1.7 | 4.0 | 5.9 | |
+/-Cat | -1.8 | 16.0 | 6.4 | 7.1 | 1.4 | |
+/-B’mrk | - | 7.2 | -4.1 | 6.6 | -2.4 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 17/10/2024 | USD 742.02 | |
Day Change | -0.52% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | LU0097089360 | |
Fund Size (Mil) 17/10/2024 | USD 3899.67 | |
Share Class Size (Mil) 17/10/2024 | USD 404.28 | |
Max Initial Charge | 1.50% | |
Ongoing Charge 29/02/2024 | 1.16% |
Investment Objective: AB - International Health Care Portfolio I Acc |
The Portfolio seeks to increase the value of investment over time through capital growth. Under normal market conditions, the Portfolio typically invests at least 80%, and not less than two thirds, of its assets in equity securities of companies in health care and health care-related industries. These companies may be located anywhere in the world, including Emerging Markets. The Portfolio may be exposed to any currency. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Vinay Thapar 01/04/2013 | ||
John Fogarty 01/07/2019 | ||
Inception Date 18/02/1999 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for AB - International Health Care Portfolio I Acc | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 8.74 |
UnitedHealth Group Inc | Healthcare | 8.39 |
Novo Nordisk AS Class B | Healthcare | 6.82 |
Merck & Co Inc | Healthcare | 6.21 |
Roche Holding AG | Healthcare | 5.71 |
Increase Decrease New since last portfolio | ||
AB - International Health Care Portfolio I Acc |